XBIO

Value 20202021202220232024 TTM Total revenue 436.94 K1.16 M1.71 M2.54 M2.5 M 2.86 M Gross profit 436.94 K1.16 M1.71 M2.54 M2.5 M 2.86 M Operating expenses 14.37 M6.91 M8.42 M7.06 M6.7 M 6.17 M Selling/general/admin expenses 3.4 M3.74 M3.65 M3.56 M3.42 M 2.84 M Research & development 1.73 M3.16 M4.77 M3.49 M3.29 M 3.33 M Operating income 13.94 M-5.75 M-6.72 M-4.52 M-4.2 M -3.31 M Non-Operating Income, Total 125.68 K101.59 K165.55 K381.14 K244.15 K 154.4 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 125.19 K100.47 K167.15 K355.76 K249.86 K 156.07 K Unusual income/expense 4921 119-1 59725.38 K-5 708 -1 677 Pretax income 14.21 M-5.65 M-6.55 M-4.13 M-3.96 M -3.16 M Equity in earnings ————— — Taxes -2.92 M0000 0 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 10.89 M-5.65 M-6.55 M-4.13 M-3.96 M -3.16 M Discontinued operations ————— — Net income 10.89 M-5.65 M-6.55 M-4.13 M-3.96 M -3.16 M Dilution adjustment 0———— — Preferred dividends 0———— — Diluted net income available to common stockholders 10.89 M-5.65 M-6.55 M-4.13 M-3.96 M -3.16 M Basic earnings per share (Basic EPS) ——-4.6-2.71-2.57 -2.05 Diluted earnings per share (Diluted EPS) ——-4.6-2.71-2.57 -2.05 Average basic shares outstanding ——1.42 M1.53 M1.54 M 6.17 M Diluted shares outstanding ——1.42 M1.53 M1.54 M 6.17 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 7570——— —